Cellulose-Based Scaffolds with Prolonged Dexamethasone Release for Bone Tissue Engineering
2025
Jolanta Liesienė | Odeta Baniukaitiene | Ieva Minseviciene
The implantation of bone substitutes is frequently accompanied by inflammation. To reduce the inflammatory response and enhance cell adhesion, proliferation, and differentiation, scaffolds are often loaded with anti-inflammatory drugs. In this study, cellulose and cellulose/hydroxyapatite (1:1 by weight) scaffolds were developed. Structural analysis using SEM and micro-computed tomography revealed that the morphology of the scaffolds met the requirements for bone tissue engineering. The scaffolds were initially loaded with dexamethasone sodium phosphate: however, the drug was released very rapidly. To prolong its release, cationic groups were introduced into the cellulose macromolecules by amination with 2-chloro-N,N-diethylethylamine hydrochloride in an alkaline medium. Dexamethasone sodium phosphate was then immobilised on aminated cellulose and aminated cellulose/HAp scaffolds at concentrations of 157 mg/g and 87 mg/g, respectively. Due to ionic interactions between the cationic groups in the scaffolds and the anionic groups of the drug molecules, drug release was effectively prolonged. After 24 h, only about 6&ndash:7% of the drug had been released, with complete release occurring after 170 h. The cationic groups in the scaffold framework facilitated the adsorption and sustained release of dexamethasone sodium phosphate.
显示更多 [+] 显示较少 [-]